While the rapid adoption of DCT approaches has helped to widen patient access, site personnel feel pressured to keep up. From inadequate staffing and complex endpoints to complicated admin and burdensome tech, the challenges are overwhelming. In this white paper, our experts uncover the need for sponsors to throw off the usual business model in favor of deeply collaborative relationships with trial sites. https://bit.ly/3DDdiPF #DCT #patientaccess
IQVIA Research & Development Solutions
Research Services
Durham, NC 64,145 followers
Using intelligent connections to accelerate your clinical trials without compromise.
About us
IQVIA Research & Development Solutions (RDS) is the full-service clinical development partner that leverages the power of IQVIA Connected Intelligence across your entire study, from study design to site selection, enrollment and execution, so you can deliver life-changing therapies faster and without compromise.
- Website
-
https://www.iqvia.com/solutions/research-and-development
External link for IQVIA Research & Development Solutions
- Industry
- Research Services
- Company size
- 10,001+ employees
- Headquarters
- Durham, NC
Updates
-
IQVIA Functional Services turns your gaps into advantages! Seamlessly connecting and customizing FSP solutions to solve your unique pain points, we’ll provide the oversight you need for greater quality control and maximum efficiency. Talk to one of our experts to learn more. https://bit.ly/3DHrW8m #FSP #FunctionalServices
-
Explore the challenges and opportunities in clinical research for AMR therapeutics, with expert perspectives on overcoming regulatory hurdles and ensuring compliance to drive progress. Catch up now with IQVIA on-demand. https://bit.ly/3DBY3qa #AMR #clinicalresearch
-
The digitalization of clinical trials was in full focus at this year’s DIA. But despite the many tech-enabled solutions in development, there’s a multitude of factors for trial sponsors, sites, and patients to consider. Here, IQVIA’s Rajneesh Patil discusses how to minimize burdens of use, protect quality data, and ensure solutions remain intuitive. Read now. https://bit.ly/4h1Kmzg #clinicaltrials #AI #ML
-
From Muscular Dystrophy and genetic syndromes to hematology and metabolic disorders, our experience spans the full spectrum of rare diseases. Discover how IQVIA’s unmatched global site network can accelerate study start-up times, enhance patient recruitment, and improve the lives of those living with rare diseases. https://bit.ly/3BVrqDg #RareDisease
-
With the increased popularity of platform clinical trials, join IQVIA’s Biostatistician Elise Covert to discover how platform clinical trials can revolutionize drug assessment and patient enrollment. Register now. https://lnkd.in/eTe4MKFX #clinicaltrials #drugassessment #patientrecruitment
-
The EU CT Regulation was implemented in January 2022 and IQVIA teams have been leading sponsors through the challenges that this ground-breaking regulation has introduced. Many in the industry have been struggling to adapt to the changes that this has brought to the clinical trial landscape in the EU. IQVIA Regulatory and GSA teams have been on-hand to support our customers through the changes. https://bit.ly/40g4GHo #regulatory #clinicaltrials
-
80% of clinical trials fail to meet initial enrollment targets and timelines. IQVIA’s AIML forecasting model predicts your study recruitment flow, reveals underlying root causes that delay patient enrollment, and informs targeted solutions that mitigate recruitment gaps. Download the fact sheet to learn more. https://bit.ly/4gXftf3 #clinicaltrials #patientenrollment #centralizedmonitoring
-
“Through early engagement, we help plan out and perform assessments throughout the entire process. Only then can a safe and efficacious cell-based therapy reach the patients that need it.” Keeping track of the information collected by a CRO and central lab can be challenging. Here, IQVIA’s Diego Correa, MD, MSc, PhD explains how we keep the process as smooth as possible. https://lnkd.in/gT24xWh2 #CAGT #cellbasedtherapy